1. Home
  2. NPK vs KROS Comparison

NPK vs KROS Comparison

Compare NPK & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPK
  • KROS
  • Stock Information
  • Founded
  • NPK 1905
  • KROS 2015
  • Country
  • NPK United States
  • KROS United States
  • Employees
  • NPK N/A
  • KROS N/A
  • Industry
  • NPK Ordnance And Accessories
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NPK Industrials
  • KROS Health Care
  • Exchange
  • NPK Nasdaq
  • KROS Nasdaq
  • Market Cap
  • NPK 655.0M
  • KROS 558.9M
  • IPO Year
  • NPK N/A
  • KROS 2020
  • Fundamental
  • Price
  • NPK $104.17
  • KROS $14.53
  • Analyst Decision
  • NPK
  • KROS Buy
  • Analyst Count
  • NPK 0
  • KROS 13
  • Target Price
  • NPK N/A
  • KROS $20.63
  • AVG Volume (30 Days)
  • NPK 181.5K
  • KROS 487.4K
  • Earning Date
  • NPK 08-05-2025
  • KROS 08-06-2025
  • Dividend Yield
  • NPK 0.95%
  • KROS N/A
  • EPS Growth
  • NPK 31.39
  • KROS N/A
  • EPS
  • NPK 5.96
  • KROS 0.11
  • Revenue
  • NPK $415,214,000.00
  • KROS $214,713,000.00
  • Revenue This Year
  • NPK N/A
  • KROS $5,006.76
  • Revenue Next Year
  • NPK N/A
  • KROS N/A
  • P/E Ratio
  • NPK $17.29
  • KROS $132.53
  • Revenue Growth
  • NPK 23.15
  • KROS 91657.70
  • 52 Week Low
  • NPK $69.80
  • KROS $9.12
  • 52 Week High
  • NPK $108.30
  • KROS $72.37
  • Technical
  • Relative Strength Index (RSI)
  • NPK 65.18
  • KROS 64.67
  • Support Level
  • NPK $103.20
  • KROS $13.26
  • Resistance Level
  • NPK $107.14
  • KROS $14.68
  • Average True Range (ATR)
  • NPK 3.13
  • KROS 0.41
  • MACD
  • NPK 0.29
  • KROS 0.12
  • Stochastic Oscillator
  • NPK 70.48
  • KROS 89.35

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: